Cooperative Agreement U19CA291404
Award Date
9/6/24
Completion Date
8/31/29
Dollars Obligated
$4M
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Cooperative Agreement
Place of Performance
Chicago, IL 60611, USA
Similar Awards
The National Cancer Institute (NCI) awarded a 5-year, $708,091 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Emory University to develop and test the effectiveness of an "Algorithm-Enabled Patients Activated in Cancer Care through Teams" (A-PACT) intervention. The A-PACT program uses machine learning algorithms to automatically identify high-risk cancer patients who can benefit from structured education and engagement in goals of care...
The Washington University was awarded a $1,887,583 Cooperative Agreement from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The goal of the 5-year WASHU-ACCERT Center is to advance cancer control equity through community-engaged, multilevel research interventions addressing the impact of social determinants of health on adverse cancer outcomes. Key objectives include: 1) Bringing innovation to cancer control equity research through...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $547,047.00 to Georgetown University to test the bundling of multicancer screening and genetic services navigation to improve cancer health equity among non-Hispanic Black and Hispanic women. The project aims to address patient- and organization-level barriers that limit cancer screening and genetic testing rates, which can contribute to disparities in breast and colorectal...
The National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), awarded a $1,909,966 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Xanthoshealth, Inc. The 24-month grant, beginning on September 20, 2024, supports the development and evaluation of ConnectedNest, a digital platform that connects individuals facing cancer with social and community services. The project aims to enhance ConnectedNest's technical infrastructure,...
This federal Project Grant award from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) provides $696,133 to Northwestern University to develop an advanced imaging platform for tracking the migration of neural stem cells (NSCs) to brain metastases of breast cancer. The key products and services to be delivered include: Optimizing a multimodal imaging approach using single-photon emission microscopy (SPEM) and magnetic resonance (MR) techniques to...
The National Cancer Institute (NCI) awarded a $3,790,188 Cooperative Agreement under the Cancer Cause and Prevention Research (CFDA 93.393) program to Virginia Commonwealth University (VCU) to establish the Virginia Advancing Cancer Control Equity Research Through Transformative Solutions (VA-ACCERT) Center. The five-year VA-ACCERT Center is an academic-public partnership that aims to improve dissemination and implementation of health promotion and cancer prevention services within...
This federal Cooperative Agreement award for $811,500.00 from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) supports research to bridge the gap between bioinformatics and mathematical modeling for patient-specific tumor modeling. The project aims to merge bioinformatics software for analyzing single-cell and spatial multi-omics data with an agent-based modeling framework to simulate cell interactions in virtual tumor environments. Key objectives include refining a cell...
This $172,197 Project Grant award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) aims to establish and refine processes to facilitate clinical trials in cancer interception (active cancer prevention) at the University of Kansas Cancer Center (KUCC). Key objectives include: Hiring project navigators to support study approvals for principal investigators in non-oncology departments outside KUCC Training research coordinators in cancer prevention trial processes...
This $2,372,456 Project Grant awarded by the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support a collaborative research program led by Memorial Sloan Kettering Cancer Center focused on leveraging observational (real-world) data to advance precision oncology. The key products and services to be delivered include: Overcoming methodological barriers in the analysis of observational clinico-genomic data (Project 1) Addressing the role of genetic ancestry...
The National Cancer Institute (NCI) awarded a $1,338,648 project grant under CFDA Program 93.393, Cancer Cause and Prevention Research, to the University of Pittsburgh. The grant will fund a hybrid effectiveness-implementation trial of the CARES intervention, which aims to improve health-related quality of life for cancer patients experiencing depression, pain, and fatigue. The study will evaluate the effectiveness of CARES in a real-world setting, conduct an implementation evaluation, and...